Molecure S.A. (MOC)
GPW
Closed
Aug 24, 2026
Day's Range
6.0052 wk Range
4.98Overview - MOC - Molecure S.A.
Key Statistics
Valuation
Enterprise Value
110.24M
P/E (Trailing)
‪-3.96‬
PEG Ratio
‪0.10‬
Price / Sales (TTM)
‪23.39‬
Price / Book
‪1.42‬
EV / EBITDA
‪-7.05‬
Profitability
Profit Margin
‪-240.64%‬
Operating Margin
‪-61.32%‬
Return on Assets
‪-27.51%‬
Return on Equity
‪-16.27%‬
Ownership
Shares Outstanding
20.20M
Float
16.30M
Held by Insiders
‪29.29%‬
Held by Institutions
‪9.31%‬
Price stats
Beta
‪1.00‬
50-Day Avg
‪5.89‬
200-Day Avg
‪6.28‬
Dividends
Payout Ratio
‪0.00%‬
Peers - MOC - Molecure S.A.
Peer Comparison
Compared with companies in Biotechnology listed on GPW.
- MOCGPWMolecure S.A.140.67MMarket Cap-0.18%52-week change-3.67P/E (Trailing)‪-240.64%‬Profit Margin
- BSTGPWBest S.A.974.02MMarket Cap+25.15%52-week change7.34P/E (Trailing)‪23.56%‬Profit Margin
- BCXGPWBioceltix S.A.442.58MMarket Cap-33.33%52-week change-26.24P/E (Trailing)‪0.00%‬Profit Margin
- BIOGPWBioton S.A.323.70MMarket Cap-11.14%52-week change75.40P/E (Trailing)‪1.52%‬Profit Margin
- APEGPWAps Energia S.A.156.71MMarket Cap+46.94%52-week change15.44P/E (Trailing)‪10.72%‬Profit Margin
- ASBPGPWAspire Biopharma Holdings Inc.7.83MMarket Cap-151.90%52-week change-0.01P/E (Trailing)‪-1.87%‬Profit Margin
- ASEPGPWAsep Medical Holdings Inc.1.44MMarket Cap-284.62%52-week change-0.10P/E (Trailing)‪-538.03%‬Profit Margin
Profile Summary - MOC - Molecure S.A.
About
Molecure S.A. is a biotechnology company focused on the development of innovative therapeutics for the treatment of serious diseases. Centered in the pharmaceutical industry, the company's primary purpose is to advance novel drug discovery, especially targeting RNA and protein complexes. Molecure employs a combination…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
